Next Article in Journal
Follow-Up for Women after Treatment for Cervical Cancer
Previous Article in Journal
Consensus Recommendations for the Diagnosis and Management of Well-Differentiated Gastroenterohepatic Neuroendocrine Tumours: A Revised Statement from a Canadian National Expert Group
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Letter

Adjuvant Interferon Alfa for Melanoma

by
Kenneth S. Wilson
and
Andrew Attwell
British Columbia Cancer Agency, Vancouver Island Centre, 2410 Lee Avenue, Victoria, BC V8R 6V5, Canada
Submission received: 1 May 2010 / Revised: 3 May 2010 / Accepted: 6 May 2010 / Published: 1 June 2010

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

The author poses the question “Why did these study results not lead to a global consensus about interferon treatment as standard of care?” [...]
Keywords: melanoma; adjuvant; interferon melanoma; adjuvant; interferon

Share and Cite

MDPI and ACS Style

Wilson, K.S.; Attwell, A. Adjuvant Interferon Alfa for Melanoma. Curr. Oncol. 2010, 17, 6-7. https://0-doi-org.brum.beds.ac.uk/10.3747/co.v17i3.511

AMA Style

Wilson KS, Attwell A. Adjuvant Interferon Alfa for Melanoma. Current Oncology. 2010; 17(3):6-7. https://0-doi-org.brum.beds.ac.uk/10.3747/co.v17i3.511

Chicago/Turabian Style

Wilson, Kenneth S., and Andrew Attwell. 2010. "Adjuvant Interferon Alfa for Melanoma" Current Oncology 17, no. 3: 6-7. https://0-doi-org.brum.beds.ac.uk/10.3747/co.v17i3.511

Article Metrics

Back to TopTop